Skip to content

Jim van Os

36 papers in the library · 1,737 citations · publishing 2004-2024

Papers

Sort Most recent Most cited

Cannabis use and cognitive biases in people with first-episode psychosis and their siblings

Psychological Medicine November 1, 2024 L. Roldán, Teresa Sánchez‐Gutiérrez, I. Fernández-Arias et al.

Background Cannabis use and familial vulnerability to psychosis have been associated with social cognition deficits. This study examined the potential relationship between cannabis use and cognitive biases underlying social cognition and functioning in patients with first episode psychosis (FEP), their siblings, and controls. Methods We analyzed a sample of 543 participants with FEP, 203...

The contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe.

Psychological Medicine May 9, 2024 J. Selten, Marta Di Forti, Diego Quattrone et al.

BACKGROUND We examined whether cannabis use contributes to the increased risk of psychotic disorder for non-western minorities in Europe. METHODS We used data from the EU-GEI study (collected at sites in Spain, Italy, France, the United Kingdom, and the Netherlands) on 825 first-episode patients and 1026 controls. We estimated the odds ratio (OR) of psychotic disorder for several groups of...

Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case–control study

Psychological Medicine May 4, 2023 Giulia Trotta, Victoria Rodriguez, Diego Quattrone et al.

Abstract Background Childhood adversity and cannabis use are considered independent risk factors for psychosis, but whether different patterns of cannabis use may be acting as mediator between adversity and psychotic disorders has not yet been explored. The aim of this study is to examine whether cannabis use mediates the relationship between childhood adversity and psychosis. Methods Data were...

The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case–control study

Psychological Medicine May 2, 2023 Edoardo Spinazzola, Diego Quattrone, Victoria Rodriguez et al.

Abstract Background While cannabis use is a well-established risk factor for psychosis, little is known about any association between reasons for first using cannabis (RFUC) and later patterns of use and risk of psychosis. Methods We used data from 11 sites of the multicentre European Gene-Environment Interaction (EU-GEI) case–control study. 558 first-episode psychosis patients (FEPp) and 567...

Influence of cannabis use on incidence of psychosis in people at clinical high risk

Psychiatry and Clinical Neurosciences April 18, 2023 Lucy Chester, Lucia Valmaggia, Matthew J. Kempton et al.

Evidence for case–control studies suggests that cannabis use is a risk factor for the development of psychosis. However, there have been limited prospective studies and the direction of this association remains controversial. The primary aim of the present study was to examine the association between cannabis use and the incidence of psychotic disorders in people at clinical high risk of...

Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis

Psychological Medicine September 12, 2022 Rajiv Radhakrishnan, L. Pries, G. Erzin et al.

Abstract Background Empirical evidence suggests that people use cannabis to ameliorate anxiety and depressive symptoms, yet cannabis also acutely worsens psychosis and affective symptoms. However, the temporal relationship between cannabis use, anxiety and depressive symptoms and psychotic experiences (PE) in longitudinal studies is unclear. This may be informed by examination of mutually...

The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

Translational Psychiatry August 10, 2021 Diego Quattrone, Ulrich Reininghaus, Anne Richards et al.

Diagnostic categories do not completely reflect the heterogeneous expression of psychosis. Using data from the EU-GEI study, we evaluated the impact of schizophrenia polygenic risk score (SZ-PRS) and patterns of cannabis use on the transdiagnostic expression of psychosis. We analysed first-episode psychosis patients (FEP) and controls, generating transdiagnostic dimensions of psychotic symptoms...

Precision psychiatry: promise for the future or rehash of a fossilised foundation?

Psychological Medicine July 1, 2021 Annemarie C J Köhne, Jim van Os

Precision psychiatry is currently described as an approach that would bring significant advance to psychiatric clinical practice. Theaim of this article is to investigate Precision Psychiatry's promise for the future; should we substantially invest in this new approach? Thearticle is based on a review of the literature and reports a conceptual analysis. A critical examination of Precision...

DOI: 10.1017/s0033291721000271 (opens in new tab) Full text (opens in new tab) Mental disorder Biomarkers Qualia Representational problem +1

Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association—The Example of Cannabis and Psychosis

Schizophrenia Bulletin March 8, 2021 Jim van Os, L. Pries, M. Ten Have et al.

Abstract Hypotheses about the link between cannabis use and psychosis apply to the within-person level but have been tested mostly at the between-person level. We used a within-person design, in which a person serves as his own control, thus removing the need to consider confounding by any fixed (genetic and nongenetic) characteristic to study the prospective association between cannabis use...

Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case–control study

Psychological Medicine March 18, 2020 Diego Quattrone, Laura Ferraro, Giada Tripoli et al. 89 citations

Abstract Background Daily use of high-potency cannabis has been reported to carry a high risk for developing a psychotic disorder. However, the evidence is mixed on whether any pattern of cannabis use is associated with a particular symptomatology in first-episode psychosis (FEP) patients. Method We analysed data from 901 FEP patients and 1235 controls recruited across six countries, as part of...

Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use

Schizophrenia Bulletin July 2, 2019 Laura Ferraro, Caterina la Cascia, Diego Quattrone et al. 25 citations

Psychotic patients with a lifetime history of cannabis use generally show better cognitive functioning than other psychotic patients. Some authors suggest that cannabis-using patients may have been less cognitively impaired and less socially withdrawn in their premorbid life. Using a dataset comprising 948 patients with first-episode psychosis (FEP) and 1313 population controls across 6...

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

The Lancet Psychiatry May 1, 2019 Marta Di Forti, Diego Quattrone, Tom P. Freeman et al.

Summary Background Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic disorder across Europe and explore whether differences in such patterns contribute to variations in the incidence rates of psychotic disorder....

Cannabis-associated symptom profiles in patients with first episode psychosis and population controls

bioRxiv (Cold Spring Harbor Laboratory) March 16, 2019 Diego Quattrone, Laura Ferraro, Giada Tripoli et al. 3 citations preprint

Abstract Objective The evidence is mixed on whether cannabis use is associated with a particular symptomatology in first episode psychosis (FEP) patients. The authors set out to investigate a) patterns of association between cannabis use and transdiagnostic symptom dimensions; b) whether the extent of use of cannabis contributes to the variation in clinical and subclinical symptom profiles....

Mindfulness-based stress reduction in middle-aged and older adults with memory complaints: a mixed-methods study.

Aging & Mental Health September 2018 Lotte Berk, Rafke Hotterbeekx, Jim van Os et al.

In a rapidly aging world population, an increasingly large group faces age-related decline in cognitive functioning. Cognitive complaints of older adults are often related to worries and concerns associated with age-related functional decline. Mindfulness-Based Stress Reduction (MBSR) can successfully target stress, worry and ruminative thinking, but the applicability of this method in...

Mindfulness Training for People With Dementia and Their Caregivers: Rationale, Current Research, and Future Directions

Frontiers in Psychology June 13, 2018 Lotte Berk, Franca C. Warmenhoven, Jim van Os et al. 66 citations

The world population is aging and the prevalence of dementia is increasing. By 2050, those aged 60 years and older are expected to make up a quarter of the population. With that, the number of people with dementia is increasing. Unfortunately, there is no cure for dementia. The progression of symptoms with no hope of improvement is difficult to cope with, both for patients and their caregivers....

The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta – analysis

PLoS One February 14, 2018 T. Vaessen, Lea de Jong, A. T. Schäfer et al.

Background Neither environmental nor genetic factors are sufficient to predict the transdiagnostic expression of psychosis. Therefore, analysis of gene-environment interactions may be productive. Objective A meta-analysis was performed using papers investigating the interaction between cannabis use and catechol-O-methyl transferase (COMT) polymorphism Val158Met (COMTVal158Met). Data sources...

Can mindfulness-based interventions influence cognitive functioning in older adults? A review and considerations for future research.

Aging & Mental Health November 2017 Lotte Berk, Martin P.j. van Boxtel, Jim van Os

An increased need exists to examine factors that protect against age-related cognitive decline. There is preliminary evidence that meditation can improve cognitive function. However, most studies are cross-sectional and examine a wide variety of meditation techniques. This review focuses on the standard eight-week mindfulness-based interventions (MBIs) such as mindfulness-based stress reduction...

Putting a Hold on the Downward Spiral of Paranoia in the Social World: A Randomized Controlled Trial of Mindfulness-Based Cognitive Therapy in Individuals with a History of Depression.

PLoS One June 10, 2016 Dina Collip, Nicole Geschwind, Frenk Peeters et al.

ContextParanoia embodies altered representation of the social environment, fuelling altered feelings of social acceptance leading to further mistrust. Mindfulness-based cognitive therapy (MBCT) may relieve paranoia and reduce its impact on social acceptance.ObjectiveTo determine whether MBCT alters momentary feeling of paranoia and social acceptance in daily life.DesignRandomized controlled...

Course of auditory vocal hallucinations in childhood: 11‐year follow‐up study

Acta Psychiatrica Scandinavica March 24, 2016 Agna A. Bartels‐Velthuis, Johanna T. W. Wigman, Jack A. Jenner et al. 68 citations

OBJECTIVE: Childhood auditory vocal hallucinations (AVH) are mostly transient but may predict clinical outcomes. Little is known about their course over time and associations with risk factors, and how this may inform early intervention. Our objective was to assess the 11-year course of AVH, associated psychopathology and risk factors. METHOD: A 5-year (T1) and 11-year (T2) follow-up of a...

Disturbed Experience of Self: Psychometric Analysis of the Self-Experience Lifetime Frequency Scale (SELF).

Psychopathology March 19, 2016 Henriëtte Dorothée Heering, Saskia Goedhart, Richard Bruggeman et al.

Background: Schizophrenia is characterized by positive and negative symptoms, but recently anomalous self-experiences, e.g. exaggerated self-consciousness (hyperreflectivity), receive more attention as an important symptom domain in schizophrenia patients. The semi-structured interview, the Examination of Anomalous Self-Experience (EASE) [Psychopathology 2005;38:236-258], examines experiences...

DOI: 10.1159/000441952 (opens in new tab) Full text (opens in new tab) Humans Depersonalization Personal satisfaction Psychotic disorders +8

Stress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling Study

Schizophrenia Bulletin February 1, 2016 Ulrich Reininghaus, Matthew J. Kempton, Lucia Valmaggia et al. 315 citations

While contemporary models of psychosis have proposed a number of putative psychological mechanisms, how these impact on individuals to increase intensity of psychotic experiences in real life, outside the research laboratory, remains unclear. We aimed to investigate whether elevated stress sensitivity, experiences of aberrant novelty and salience, and enhanced anticipation of threat contribute...

Default mode network connectivity as a function of familial and environmental risk for psychotic disorder.

PLoS One 2015 Sanne C. T. Peeters, Vincent G Van de Ven, Ed H B M Gronenschild et al.

Research suggests that altered interregional connectivity in specific networks, such as the default mode network (DMN), is associated with cognitive and psychotic symptoms in schizophrenia. In addition, frontal and limbic connectivity alterations have been associated with trauma, drug use and urban upbringing, though these environmental exposures have never been examined in relation to DMN...

Effects of mindfulness-based cognitive therapy on self-reported suicidal ideation: results from a randomised controlled trial in patients with residual depressive symptoms.

Comprehensive Psychiatry November 2014 Thomas Forkmann, Marieke Wichers, Nicole Geschwind et al.

The aim of the present study was to investigate the effects of mindfulness-based cognitive therapy (MBCT) on suicidal ideation in an open-label randomised controlled trial of patients with residual depressive symptoms. Furthermore, this study aimed at examining whether an effect of MBCT on suicidal ideation was dependent on a reduction in depression severity, worry and rumination, or an...

How Does MBCT for Depression Work? Studying Cognitive and Affective Mediation Pathways

PLoS One August 23, 2013 T. Batink, Frenk Peeters, Nicole Geschwind et al.

Mindfulness based cognitive therapy (MBCT) is a non-pharmacological intervention to reduce current symptoms and to prevent recurrence of major depressive disorder. At present, it is not well understood which underlying mechanisms during MBCT are associated with its efficacy. The current study (n = 130) was designed to examine the roles of mindfulness skills, rumination, worry and affect, and...

Cannabis use and vulnerability for psychosis in early adolescence—a TRAILS study

Addiction December 10, 2012 Merel F. H. Griffith‐Lendering, Johanna T. W. Wigman, Andrea Prince van Leeuwen et al. 67 citations

AIMS: To examine the direction of the longitudinal association between vulnerability for psychosis and cannabis use throughout adolescence. DESIGN: Cross-lagged path analysis was used to identify the temporal order of vulnerability for psychosis and cannabis use, while controlling for gender, family psychopathology, alcohol use and tobacco use. SETTING: A large prospective population study of...